Chief Executive Officer
Dr. Revers is a leading consultant to major Pharma on biologics and biosimilars, including Hoffmann-LaRoche, Amgen and Janssen. He is a tenured Associate Professor in the department of Chemical & Physical Sciences and is cross-appointed to the Institute for Management & Innovation at the University of Toronto. Leigh was awarded a doctoral degree from the University of Oxford, and has conducted healthcare research at most of Canada’s top institutes, including the Hospital for Sick Children, the Samuel Lunenfeld Research Institute and the Ontario Cancer Institute at Princess Margaret Hospital. Together with Drs. Gariépy and Howard, he was the co-founder of both Molecular Templates Inc.(Canada), now relocated to Austin, Texas, and D5Pharma.